If you are not happy with the results below please do another search
Great changes are coming in GlaxoSmithKline. The reason for this is the new CEO Emma Walmsley, who plans to make changes to improve the company’s performance. Major changes will occur in R&D. At first glance, Walmsley seems to be acting on a pattern that her predecessor, Andrew Whittey, left, with a focus on pharmaceuticals, consumer…
GlaxoSmithKline hopes to get its new Benlysta formula under lupus patients’ skin—literally. The company won FDA approval last week for a subcutaneous version of the immunology med, previously delivered only intravenously. This means that patients will be able to treat themselves with Benlysta, rather than coming to the doctor’s office every month for a one-hour…
The death rate from cancer in Russia is higher than in advanced countries in the fight against cancer, announced Vice Premier Olga Golodets at a meeting of the Government Council on Social Welfare. “In Russian Federation, 3.5 million people suffer from cancer diseases, the number of newly diagnosed cases is more than 500 thousand per…
On Government of the Russian Federation website information, that the State Duma will soon get acquainted with the package of bills on the introduction of the state information system for monitoring the movement of medicinal products for medical use from the manufacturer to the final consumer, was appeared. The government noted that control signs will…
The reputation of the pharmaceutical industry among patients in the US has fallen to a minimum in recent years. Some experts note that the policy of current president could have caused such reaction. Only 29% of the recently interviewed respondents by the research firm PatientView believe that representatives of the pharmaceutical industry have “excellent” or…
In the United States, Takeda employees in R&D and vaccines were invited to move from suburban Chicago to the Boston area as part of a two-year program to locate workers in its scientific hub. According to Modern Healthcare, 600 R&D employees and 150 vaccine workers, total 750, based in Deerfield, Illinois, were required to move…